Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2018 Jan 15

PMID 29331961

Citations 5

Authors

Laurent Derex

Chloe Paris

Norbert Nighoghossian

Affiliations

Soon will be listed here.

Citing Articles

Progress in enzyme-powered micro/nanomotors in diagnostics and therapeutics.

Zhao J, Wang B, Yan M, Liu Y, Zhao R, Wang X Bioact Mater. 2025; 46:555-568.

PMID: 39896991 PMC: 11782855. DOI: 10.1016/j.bioactmat.2024.12.022.

Malignancy-associated ischemic stroke: Implications for diagnostic and therapeutic workup.

Xie W, Hsu S, Lin Y, Xie L, Jin X, Zhu Z CNS Neurosci Ther. 2024; 30(3):e14619.

PMID: 38532275 PMC: 10965754. DOI: 10.1111/cns.14619.

Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets.

Guan I, Liu J, Sawyer R, Li X, Jiao W, Jiramongkol Y ACS Cent Sci. 2024; 10(2):344-357.

PMID: 38435523 PMC: 10906253. DOI: 10.1021/acscentsci.3c00822.

Improving treatment for acute ischemic stroke-Clot busting innovation in the pipeline.

Liu J, Ding Y, Schoenwaelder S, Liu X Front Med Technol. 2022; 4:946367.

PMID: 35978568 PMC: 9376378. DOI: 10.3389/fmedt.2022.946367.

Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine.

Chen Y, Ju L Stroke Vasc Neurol. 2020; 5(2):185-197.

PMID: 32606086 PMC: 7337368. DOI: 10.1136/svn-2019-000302.

References

Morris D, Silver B, Mitsias P, Lewandowski C, Patel S, Daley S . Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab. Acad Emerg Med. 2003; 10(12):1396-9. DOI: 10.1111/j.1553-2712.2003.tb00016.x. View

Rebeiz A, Johanson P, Green C, Crater S, Roe M, Langer A . Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). Am J Cardiol. 2005; 95(5):611-4. DOI: 10.1016/j.amjcard.2004.10.038. View

Goyal M, Menon B, van Zwam W, Dippel D, Mitchell P, Demchuk A . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31. DOI: 10.1016/S0140-6736(16)00163-X. View

Straub S, Junghans U, Jovanovic V, Wittsack H, Seitz R, Siebler M . Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke. 2004; 35(3):705-9. DOI: 10.1161/01.STR.0000117094.41638.EE. View

Barreto A, Ford G, Shen L, Pedroza C, Tyson J, Cai C . Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke). Stroke. 2017; 48(6):1608-1616. PMC: 5499711. DOI: 10.1161/STROKEAHA.117.016720. View

Antman E, Anbe D, Armstrong P, Bates E, Green L, Hand M . ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise.... Circulation. 2004; 110(5):588-636. DOI: 10.1161/01.CIR.0000134791.68010.FA. View

Pancioli A, Broderick J, Brott T, Tomsick T, Khoury J, Bean J . The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke. 2008; 39(12):3268-76. PMC: 2588546. DOI: 10.1161/STROKEAHA.108.517656. View

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

Durand A, Chauveau F, Cho T, Kallus C, Wagner M, Boutitie F . Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke. Cerebrovasc Dis. 2014; 38(4):268-75. DOI: 10.1159/000366266. View

10.

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317-29. DOI: 10.1056/NEJMoa0804656. View

11.

Zinkstok S, Roos Y . Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet. 2012; 380(9843):731-7. DOI: 10.1016/S0140-6736(12)60949-0. View

12.

Gahn G, Barlinn K, Dzialowski I, Puetz V, Kunz A, Hentschel H . Combined thrombolysis with abciximab and rtPA in patients with middle cerebral artery occlusion. Acta Neurol Scand. 2010; 121(1):63-6. DOI: 10.1111/j.1600-0404.2009.01241.x. View

13.

Derex L, Nighoghossian N . Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008; 79(10):1093-9. DOI: 10.1136/jnnp.2007.133371. View

14.

Seitz R, Meisel S, Moll M, Wittsack H, Junghans U, Siebler M . The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology. 2004; 62(11):2110-2. DOI: 10.1212/01.wnl.0000129480.17345.4a. View

15.

Saqqur M, Uchino K, Demchuk A, Molina C, Garami Z, Calleja S . Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007; 38(3):948-54. DOI: 10.1161/01.STR.0000257304.21967.ba. View

16.

Mikulik R, Dufek M, Goldemund D, Reif M . A pilot study on systemic thrombolysis followed by low molecular weight heparin in ischemic stroke. Eur J Neurol. 2006; 13(10):1106-11. DOI: 10.1111/j.1468-1331.2006.01458.x. View

17.

Barreto A, Alexandrov A . Adjunctive and alternative approaches to current reperfusion therapy. Stroke. 2012; 43(2):591-8. PMC: 3268680. DOI: 10.1161/STROKEAHA.111.617902. View

18.

Morris D, Zhang L, Zhang Z, Lu M, Berens K, Brown P . Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke. 2001; 32(11):2635-40. DOI: 10.1161/hs1101.097390. View

19.

Adeoye O, Sucharew H, Khoury J, Vagal A, Schmit P, Ewing I . Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial. Stroke. 2015; 46(9):2529-33. PMC: 4550507. DOI: 10.1161/STROKEAHA.115.010260. View

20.

Khatri P, Mono M . Combining antithrombotic and fibrinolytic agents: can it be done?. Stroke. 2013; 44(5):1489-91. PMC: 3840505. DOI: 10.1161/STROKEAHA.111.000090. View